| Name | Title | Contact Details |
|---|
Therapak is a Duarte, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Bonutti Clinic is a Effingham, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Vertiflex is committed to delivering clinically proven treatments for lumbar stenosis that are minimally invasive in order to help people take back their lives.
Humanscale is the premier designer and manufacturer of sustainable, high-performance ergonomic products for the workplace. Our award-winning solutions improve the health, efficiency and quality of work life. Since its founding in 1983, Humanscale has held the belief that design based on functionality and ease of use results in honest and enduring forms. Humanscale`s simple, elegant solutions stand the test of time—both functionally and aesthetically—while consuming as little of the Earth`s limited resources as possible. Nearly every Humanscale product can contribute to the achievement of LEED-CI, -NC and -EB credits. In addition to manufacturing premier ergonomic work tools, Humanscale`s team of certified ergonomists is available to help organizations further improve worker comfort, reduce injuries, and boost productivity through ergonomic assessments, training, and program development. With headquarters in New York City, Humanscale`s showrooms, offices and manufacturing facilities are strategically located throughout North America, Europe, Asia and Australia, while a worldwide network of esteemed distributors enables Humanscale solutions to reach every corner of the globe.
At T2 Biosystems, we are united in our mission: to improve patient outcomes, lower mortality rates and reduce the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. By leveraging the power of our innovative and proprietary T2 Magnetic Resonance (T2MR) platform, T2 Biosystems’ diagnostics are designed to provide faster, easier and more accurate results than traditional methodologies. T2 Biosystems is currently targeting a range of critically underserved healthcare conditions, focusing initially on those for which a rapid diagnosis will serve an important dual role – saving lives and reducing costs. Our T2Candida Panel tackles sepsis and is the first FDA-cleared diagnostic panel requiring no blood culture – delivering more accurate results in hours versus days. Other ongoing development efforts include bacterial and hemostasis panels, as well as a Lyme disease partnership with Canon Life Sciences. Over 100 studies published in peer-reviewed journals have featured T2MR technology in a breadth of applications, including the direct detection and measurement of targets in various sample types, such as whole blood, plasma, serum, saliva, sputum and urine. With limits of detection as low as 1 CFU/mL, we believe T2MR technology will drive the next generation of diagnostics.